Sign in

CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company

Aprea Therapeutics, Inc.

Sign in to watch
Ticker
APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
215-948-4119
Business address
3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award President, CEO acquired 4,000 shares (grant or award)
  4. 4 Grant or award SrVP/CFO/Prin Fin & Acct Ofcr acquired 1,000 shares (grant or award)
  5. 4 Grant or award SrVP/CFO/Prin. Fin&Acctg. Off acquired 269,879 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Grant or award Director acquired 5,995 shares (grant or award)
  8. 4 Grant or award Director acquired 32,400 shares (grant or award)
  9. 4 Grant or award Director acquired 5,995 shares (grant or award)
  10. 4 Grant or award Director acquired 5,995 shares (grant or award)
  11. 4 Grant or award SVP, Chief Operating Officer acquired 24,300 shares (grant or award)
  12. 4 Grant or award Director acquired 5,995 shares (grant or award)
  13. 4 Grant or award Director acquired 5,995 shares (grant or award)
  14. 4 Grant or award President, CEO acquired 101,300 shares (grant or award)
  15. 4 Grant or award Director acquired 5,995 shares (grant or award)
  16. 4 Grant or award SVP, Chief Financial Officer acquired 60,800 shares (grant or award)
  17. 4 Shares withheld for taxes Chairman & CEO gave up 65,770 shares (to pay taxes)
  18. 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 35,284 shares (to pay taxes)
  19. 4 Shares withheld for taxes SVP, Chief Operating Officer gave up 8,390 shares (to pay taxes)
  20. 4 Shares withheld for taxes SVP, Chief Medical Officer gave up 32,667 shares (to pay taxes)

Page 4 of 9 · 180 filings